Differences between Orofacial Inflammation and Cancer Pain

Rat models of orofacial cancer exhibit both allodynia and hyperalgesia; however, it is unclear whether cancer-induced pain is secondary to cancer-induced inflammation. To address this question, we compared the effects of an anti-inflammatory drug, indomethacin, on pain and neurochemical changes in t...

Full description

Saved in:
Bibliographic Details
Published inJournal of dental research Vol. 89; no. 6; pp. 615 - 620
Main Authors Harano, N., Ono, K., Hidaka, K., Kai, A., Nakanishi, O., Inenaga, K.
Format Journal Article
LanguageEnglish
Published Los Angeles, CA SAGE Publications 01.06.2010
International Association for Dental Research
SAGE PUBLICATIONS, INC
Subjects
Rat
Online AccessGet full text

Cover

Loading…
More Information
Summary:Rat models of orofacial cancer exhibit both allodynia and hyperalgesia; however, it is unclear whether cancer-induced pain is secondary to cancer-induced inflammation. To address this question, we compared the effects of an anti-inflammatory drug, indomethacin, on pain and neurochemical changes in the medullary dorsal horn in orofacial inflammation and cancer models. Daily peripheral administration of indomethacin largely suppressed mechanical allodynia and thermal hyperalgesia in the inflammation model. The same procedure suppressed allodynia and hyperalgesia in the cancer model, but the suppression was weak when compared with that in the inflammation model. In the medullary dorsal horn, calcitonin gene-related peptide and substance P levels were significantly increased in the inflammation model, but did not change in the cancer model. These results suggest that pain in the orofacial cancer model is not significantly mediated by cancer-induced peripheral inflammation, although it may have some involvement.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0022-0345
1544-0591
DOI:10.1177/0022034510363095